Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosisOlga Halle, Anna‐Maria Dittrich, Sophia T. Pallenberg et al.|European Respiratory Journal|2025Cited by 12
P134 Long-term reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor in cystic fibrosisOlga Halle, Anna‐Maria Dittrich, Simon Y. Graeber et al.|Journal of Cystic Fibrosis|2025Cited by 0
645 Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosisOlga Halle, Anna‐Maria Dittrich, Simon Y. Graeber et al.|Journal of Cystic Fibrosis|2025Cited by 0